BioSpace News Archive

Business

Mispro Announces Opening of Vivarium Research Facility in Farmingdale, NY

Vivarium Space & Services Provider Expands its Network to Long Island Bioscience Park

May 8, 2019
·
4 min read
Deals

BerGenBio ASA: Results for the First Quarter 2019

BerGenBio ASA selective AXL kinase inhibitors for multiple cancer indications, announces its results for the first quarter 2019.

May 8, 2019
·
6 min read
Deals

Calliditas Therapeutics: Interim Report Q1, 2019

This first quarter of 2019, we were busy ensuring that the recruitment efforts for our pivotal phase 3 study NefIgArd remain on track, focusing on site initiation visits and supporting our CRO in their work to ensure that all sites are brought online on a timely manner.

May 8, 2019
·
3 min read
Deals

West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conferences

West Pharmaceutical Services, Inc. announced that the Company’s Board of Directors has approved a third-quarter 2019 dividend of $0.15 per share.

May 8, 2019
·
1 min read
Deals

Vitamin Shoppe, Inc. Announces First Quarter 2019 Results

Vitamin Shoppe, Inc. announced preliminary results for the three months ended March 30, 2019.

May 8, 2019
·
10 min read
Drug Development

BerGenBio Completes Recruitment Into Second Stage of Phase II Trial With Selective AXL inhibitor bemcentinib in Combination with KEYTRUDA® in Patients With Advanced NSCLC

Phase II, Simon two-stage trial evaluating bemcentinib and KEYTRUDA in previously treated NSCLC post chemotherapy (Cohort A, NCT03184571)

May 8, 2019
·
5 min read
Drug Development

AAN 2019: Two New Analyses of Lasmiditan Phase 3 Studies Measured Onset of Effect and the Effect of Lasmiditan in Patients with Prior Triptan Experience

The lasmiditan Phase 3 program encompassed more than 4,000 patients and 20,000 migraine attacks

May 8, 2019
·
11 min read
Biotech Beach

ITT Veam and Cannon to Showcase Portfolio of High-Performance Rail Interconnect Solutions at Railtex 2019 in Birmingham, UK

ITT to demonstrate its extensive rail connector expertise for both exterior and in-vehicle applications

May 8, 2019
·
3 min read
Deals

Pfizer Acquires Clinical-Stage Biotech Therachon

Expands Pfizer’s rare disease portfolio with potential first-in-class therapy for achondroplasia, a genetic condition and the most common form of short-limb dwarfism

May 8, 2019
·
8 min read
Deals

Hill-Rom Declares Fiscal 2019 Third Quarter Dividend

Hill-Rom Holdings, Inc., announced that its board of directors declared a fiscal 2019 third quarter dividend of $0.21 per share payable on June 28, 2019, to shareholders of record as of the close of business on June 21, 2019.

May 8, 2019
·
1 min read